Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Characterization and Proteome of Circulating Extracellular Vesicles as Potential Biomarkers for NASH
Davide Povero, Hirokazu Yamashita, Wenhua Ren, et al.
Hepatology Communications (2020) Vol. 4, Iss. 9, pp. 1263-1278
Open Access | Times Cited: 89

Showing 1-25 of 89 citing articles:

Exosomes as mediators of intercellular crosstalk in metabolism
Roi Isaac, Felipe C.G. Reis, Wei Ying, et al.
Cell Metabolism (2021) Vol. 33, Iss. 9, pp. 1744-1762
Open Access | Times Cited: 466
Modern isolation and separation techniques for extracellular vesicles
Thanaporn Liangsupree, Evgen Multia, Marja‐Liisa Riekkola
Journal of Chromatography A (2020) Vol. 1636, pp. 461773-461773
Open Access | Times Cited: 356
Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver/steatohepatitis (NAFL/NASH)
Xiaohan Xu, Kyle L. Poulsen, Lijuan Wu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 202
Preserving extracellular vesicles for biomedical applications: consideration of storage stability before and after isolation
Fumin Yuan, Yamin Li, Zhuhui Wang
Drug Delivery (2021) Vol. 28, Iss. 1, pp. 1501-1509
Open Access | Times Cited: 114
Mitochondria, oxidative stress and nonalcoholic fatty liver disease: A complex relationship
Agnieszka Karkucińska‐Więckowska, Inês C. M. Simões, Piotr Kalinowski, et al.
European Journal of Clinical Investigation (2021) Vol. 52, Iss. 3
Open Access | Times Cited: 105
Non-invasive diagnosis and monitoring of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
Monica A. Tincopa, Rohit Loomba
˜The œLancet. Gastroenterology & hepatology (2023) Vol. 8, Iss. 7, pp. 660-670
Closed Access | Times Cited: 84
Liver fibrosis in NAFLD/NASH: from pathophysiology towards diagnostic and therapeutic strategies
Maurizio Parola, Massimo Pinzani
Molecular Aspects of Medicine (2023) Vol. 95, pp. 101231-101231
Open Access | Times Cited: 62
Clinical and Molecular Biomarkers for Diagnosis and Staging of NAFLD
Stefania Di Mauro, Alessandra Scamporrino, Agnese Filippello, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11905-11905
Open Access | Times Cited: 68
Adipose Tissue-Derived Mesenchymal Stem/Stromal Cells and Their Contribution to Angiogenic Processes in Tissue Regeneration
Agnieszka Krawczenko, Aleksandra Klimczak
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2425-2425
Open Access | Times Cited: 64
Role of extracellular vesicles in liver diseases and their therapeutic potential
Enis Kostallari, Shantha Valainathan, Louise Biquard, et al.
Advanced Drug Delivery Reviews (2021) Vol. 175, pp. 113816-113816
Open Access | Times Cited: 59
NASH and Hepatocellular Carcinoma: Immunology and Immunotherapy
Matthias Pinter, David J. Pinato, Pierluigi Ramadori, et al.
Clinical Cancer Research (2022) Vol. 29, Iss. 3, pp. 513-520
Open Access | Times Cited: 59
Selective Isolation of Liver-Derived Extracellular Vesicles Redefines Performance of miRNA Biomarkers for Non-Alcoholic Fatty Liver Disease
Lauren A. Newman, Zivile Useckaite, Jillian G. Johnson, et al.
Biomedicines (2022) Vol. 10, Iss. 1, pp. 195-195
Open Access | Times Cited: 47
Comparison of extracellular vesicle isolation processes for therapeutic applications
Soraya Williams, María Fernández‐Rhodes, Alice Law, et al.
Journal of Tissue Engineering (2023) Vol. 14, pp. 204173142311746-204173142311746
Open Access | Times Cited: 29
Extracellular Vesicles as Delivery Vehicles for Non-Coding RNAs: Potential Biomarkers for Chronic Liver Diseases
Arianna Ferro, Gabriele Saccu, Simone Mattivi, et al.
Biomolecules (2024) Vol. 14, Iss. 3, pp. 277-277
Open Access | Times Cited: 13
The Landscape of Exosomes Biogenesis to Clinical Applications
Haitham Al‐Madhagi
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 3657-3675
Open Access | Times Cited: 12
Role and therapeutic perspectives of extracellular vesicles derived from liver and adipose tissue in metabolic dysfunction-associated steatotic liver disease
Wandi Li, Lili Yu
Artificial Cells Nanomedicine and Biotechnology (2024) Vol. 52, Iss. 1, pp. 355-369
Open Access | Times Cited: 11
Hepatic sphingomyelin phosphodiesterase 3 promotes steatohepatitis by disrupting membrane sphingolipid metabolism
Jie Jiang, Yuqing Gao, Jiang Wang, et al.
Cell Metabolism (2025)
Closed Access | Times Cited: 1
Roles of extracellular vesicles from different origins in metabolic-associated fatty liver disease: progress and perspectives
Xinyi Wang, Sônia Nair Báo, Qi An, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access | Times Cited: 1
Circulating cell-specific extracellular vesicles as biomarkers for the diagnosis and monitoring of chronic liver diseases
Lauren A. Newman, Kate Muller, Andrew Rowland
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 5
Open Access | Times Cited: 32
The Role of Endoplasmic Reticulum in Lipotoxicity during Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD) Pathogenesis
Nanditha Venkatesan, Luke C. Doskey, Harmeet Malhi
American Journal Of Pathology (2023) Vol. 193, Iss. 12, pp. 1887-1899
Open Access | Times Cited: 22
Proteomic analysis of serum extracellular vesicles reveals Fibulin-3 as a new marker predicting liver-related events in MASLD
Sadatsugu Sakane, Hayato Hikita, Kumiko Shirai, et al.
Hepatology Communications (2024) Vol. 8, Iss. 6
Open Access | Times Cited: 7
Circulating extracellular vesicles are a biomarker for NAFLD resolution and response to weight loss surgery
Yasuhiko Nakao, Pouya Amrollahi, Gopanandan Parthasarathy, et al.
Nanomedicine Nanotechnology Biology and Medicine (2021) Vol. 36, pp. 102430-102430
Open Access | Times Cited: 39
How to Identify Advanced Fibrosis in Adult Patients with Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) Using Ultrasound Elastography—A Review of the Literature and Proposed Multistep Approach
Mădălina-Gabriela Țâru, Lidia Neamți, Vlad Țâru, et al.
Diagnostics (2023) Vol. 13, Iss. 4, pp. 788-788
Open Access | Times Cited: 15
Controversies and Opportunities in the Use of Inflammatory Markers for Diagnosis or Risk Prediction in Fatty Liver Disease
Joeri Lambrecht, Frank Tacke
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 32
Transcriptomic Profiling of the Liver Sinusoidal Endothelium during Cirrhosis Reveals Stage-Specific Secretory Signature
Nicolò Manicardi, Anabel Fernández‐Iglesias, Laia Abad‐Jordà, et al.
Cancers (2021) Vol. 13, Iss. 11, pp. 2688-2688
Open Access | Times Cited: 32
Page 1 - Next Page

Scroll to top